<DOC>
	<DOCNO>NCT01342380</DOCNO>
	<brief_summary>Obtain phenotypic data DNA/blood sample mood disorder patient undergo pioglitazone quetiapine XR treatment part IRB approve clinical trial conduct Mood Disorders Program . Pioglitazone treatment examine metabolic syndrome comorbid bipolar depression ( IRB # 07-08-24 ) unipolar depression ( IRB # 07-07-20 ) . Quetiapine XR treatment examine generalized anxiety disorder comorbid bipolar depression ( IRB # 10-06-19 ) unipolar depression ( IRB # 12-01-29 ) . Please refer respective IRB protocols information .</brief_summary>
	<brief_title>Pioglitazone Quetiapine XR Pharmacogenetic Study</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Must participate IRB protocol 100619 , 120729 , 070720 , 070824 Patient must give consent participate , sign date IRB approve write informed consent form prior initiation procedure study Patient must diagnose Bipolar Disorder Major Depressive Disorder Patient must least 18 year old Patient must willing give blood sample Patient lack capacity provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>